No Data
No Data
Home Healthcare Inflation Is Stubbornly High -- WSJ
Top 3 Health Care Stocks You'll Regret Missing This Month
SurModics (SRDX) Loses -13.87% in 4 Weeks, Here's Why a Trend Reversal May Be Around the Corner
Surmodics Expands Thrombectomy Line, FDA-Cleared Pounce XL Thrombectomy System Targets Larger Arteries, Full Launch Coming Soon
Express News | Surmodics Announces Successful Early Clinical Use of Pounce™ Xl Thrombectomy System, Suitable for Non-Surgical Removal of Thrombi and Emboli From Iliac and Femoral Arteries
Barrington Maintains SurModics(SRDX.US) With Hold Rating
Unlock the Full List